CRISPR-Cas12a-based Detection of Monkeypox Virus

Yutong Sui,Qi Xu,Mingsheng Liu,Kuiyang Zuo,Xiaomei Liu,Jinyu Liu

DOI: https://doi.org/10.1016/j.jinf.2022.08.043

2022-01-01

Abstract:We read with interest the recently published research in Journal of Infection by Dr. Usman Ayub Awan et al., who emphasized that the remerging monkeypox is a new threat to the world [[1]Li D. Liu Y. Li K. Zhang L. Targeting F13 from monkeypox virus and variola virus by tecovirimat: molecular simulation analysis.J. Infect. 2022; Abstract Full Text Full Text PDF Scopus (4) Google Scholar]. Monkeypox has been declared a public health emergency of international concern by the World Health Organization (WHO) on 23 July 2022. Between 1 January and 25 August 2022, it has resulted in more than 46,700 laboratory confirmed cases of monkeypox and 12 deaths worldwide in 75 countries [[2]Alakunle E.F. Okeke M.I. Monkeypox virus: a neglected zoonotic pathogen spreads globally.Nat. rev. Microbiol. 2022; 20: 507-508Crossref PubMed Scopus (12) Google Scholar]. Public health authorities are proactively identifying cases and tracing their contacts to contain its spread. As with COVID-19, PCR is the current method capable of being deployed at sufficient speed to provide timely feedback on any public health interventions [[3]Huggett J.F. French D. O'Sullivan D.M. Moran-Gilad J. Zumla A. Monkeypox: another test for PCR. Euro surveillance: bulletin Europeen sur les maladies transmissibles.Eur. commun. dis. bull. 2022; : 27Google Scholar]. However, standard RT-qPCR methods that require laboratory-based testing instruments such as a thermal cycler for DNA amplification have constraints, including high cost, detection time, and the need for trained experts, limiting their application in point-of-care (POC) testing and resource-limited areas. Thus, the development of novel detection strategies for monkeypox is still urgent needed. CRIPSR-based detection strategies have been widely used to detect of various viruses [[4]Broughton J.P. Deng X. Yu G. et al.CRISPR-Cas12-based detection of SARS-CoV-2.Nat. Biotechnol. 2020; 38: 870-874Crossref PubMed Scopus (1177) Google Scholar,[5]Chen J.S. Ma E. Harrington L.B. et al.CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.Science. 2018; 360: 436-439Crossref PubMed Scopus (1287) Google Scholar]. In this study, we report the development and initial validation of a CRIPSR-Cas12a-based assay for detection of monkeypox virus. We designed the system that detect the monkeypox viral DNA by using fluorescence readout. In the presence of the DNA target analyte, the G-quadruplex oligonucleotide (Table 1), which is labeled with 6-fluorescein (6-FAM) on the 3′-end and black hole-1 quencher (BHQ-1) on the 5′-end, gets degraded through Cas12a-mediated collateral cleavage resulting in fluorescent signal. While in the absence of the DNA target analyte, Cas12a cannot cleave the fluorescently-labeled G-quadruplex oligonucleotides and the oligonucleotides can formation G-quadruplex structures in 100 mM K+condition, resulting in the fluorescence quenching (Fig. 1A). We found that the FAM fluorescent signal was detectable in 2 min and a strong signal was achieved within 10 min (Fig. 1B), suggesting the system is a potential rapid detection technology. In addition, we used the system to detect the F3L and N3R genes (Table 1). DNA samples of F3L and N3R genes in the same concentration range (from 0.2 fM to 100 nM) were subjected to the system, and the enhanced FAM fluorescence signal with monkeypox DNA was statistically significant (P < 0.01) at concentrations as low as 2 fM (Fig. 1C and 1D), indicating the high sensitivity of our system for monkeypox virus detection.Table 1Oligonucleotides in this study.NameSequences (5′→3′)Fluorescently-labeled G-quadruplex oligonucleotidesP4-WTBHQ-GGGTTAGGGTTAGGGTTAGGG-FAMCRISPR Cas12a gRNA sequencesF3L-gRNATCACAATGAAATATTATGTTN3R-gRNATAACGGCGACGAATATACTG Open table in a new tab In summary, we develop a rapid, easy-to-implement and accurate CRISPR-Cas12a-based system for detection of monkeypox virus. Our CRISPR-based assay provides a visual and faster alternative to current PCR-based diagnosis for monkeypox virus. J.Y.L. was the principal investigator who conceived and designed the study, obtained financial supports and approved the final version of the manuscript. Y.T.S. conducted the functional, mechanism and partial biophysical experiments, performed the statistical analyses, interpreted the results and drafted manuscript. Q.X. helped to conduct partial functional and mechanism experiments. M.S.L. and K.Y.Z. conducted data management. All the authors read and approved the final version of the manuscript. Not applicable. Not applicable. Financial support was provided by the National Program of China (82073581).